Financials

  • Market Capitalization 768.61 M
  • Employee 159
  • Founded 2015
  • CEO N/A
  • Website www.ars-pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00FZQGXG3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.7
Relación precio/flujo de caja
13.63

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2609
CTMX
CytomX Therapeutics, Inc. - Common Stock
3.70 USD-1.60%-3.90%+21.31%+56.12%805.50 M USD
2632
ZVRA
Zevra Therapeutics, Inc. - Common Stock
13.18 USD-1.27%-5.79%+2.89%+23.87%779.14 M USD
2642
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
41.30 USD-2.94%+1.57%+24.25%+37.07%764.14 M USD
2650
CLYM
Climb Bio, Inc. - Common Stock
13.21 USD-5.64%+0.30%+13.29%+141.50%756.41 M USD

Noticias